Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Prostate Cancer

  Free Subscription


Articles published in Prog Urol

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    July 2019
  1. ROSE DITE MODESTINE J, Neuzillet Y, Herve JM, Bosset PO, et al
    [12-year history of radical surgery indications for the treatment of prostate cancer].
    Prog Urol. 2019 Jul 4. pii: S1166-7087(19)30157.
    PubMed     Text format     Abstract available


    June 2019
  2. KLEINCLAUSS F, Frontczak A, Balssa L, Lebdai S, et al
    [Vascular targeted photodynamic therapy in low-risk prostate cancer. A literature review].
    Prog Urol. 2019 Jun 29. pii: S1166-7087(19)30113.
    PubMed     Text format     Abstract available


    January 2019
  3. DELPORTE G, Olivier J, Ruffion A, Crouzet S, et al
    [Evolution of the number of incident cases, stage and first treatments for prostate cancer in France between 2001 and 2016].
    Prog Urol. 2019 Jan 8. pii: S1166-7087(18)30684.
    PubMed     Text format     Abstract available


    December 2018
  4. MOUREAUX C, Boucaud-Maitre D, Brureau L, Gourtaud G, et al
    [Pelvimetrics measures as predictives factors of positives surgical margins after robot-assisted laparoscopic prostatectomy].
    Prog Urol. 2018;28:906-914.
    PubMed     Text format     Abstract available


  5. THEVENIAUD PE, Zafar N, Hajj AE, Germain A, et al
    Mid term functional results following surgical treatment of recto-urinary fistulas postprostate cancer treatment.
    Prog Urol. 2018;28:915-920.
    PubMed     Text format     Abstract available


    November 2018
  6. ROZET F, Hennequin C, Beauval JB, Beuzeboc P, et al
    [French ccAFU guidelines - Update 2018-2020: Prostate cancer].
    Prog Urol. 2018 Nov 1. pii: S1166-7087(18)30514.
    PubMed     Text format     Abstract available


    October 2018
  7. PATARD PM, Roumiguie M, Prudhomme T, Doumerc N, et al
    Migration in last decade to high-risk prostate cancer after radical prostatectomy.
    Prog Urol. 2018 Oct 15. pii: S1166-7087(18)30557.
    PubMed     Text format     Abstract available


  8. ARNOUIL N, Gelet A, Matillon X, Rouviere O, et al
    [Focal HIFU vs robot-assisted total prostatectomy: Functionnal and oncologic outcomes at one year].
    Prog Urol. 2018;28:603-610.
    PubMed     Text format     Abstract available


    September 2018
  9. DELPORTE G, Henon F, Ploussard G, Briganti A, et al
    Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature.
    Prog Urol. 2018 Sep 24. pii: S1166-7087(18)30472.
    PubMed     Text format     Abstract available


  10. AOUN F, Slaoui A, Walid EHO, Albisinni S, et al
    Association between phosphodiesterase type 5 inhibitors and prostate cancer: A systematic review.
    Prog Urol. 2018 Sep 7. pii: S1166-7087(18)30182.
    PubMed     Text format     Abstract available


  11. MEUNIER ME, Neuzillet Y, Radulescu C, Cherbonnier C, et al
    [Does the delay from prostate biopsy to radical prostatectomy influence the risk of biochemical recurrence?]
    Prog Urol. 2018;28:475-481.
    PubMed     Text format     Abstract available


    June 2018
  12. GURY L, Robert G, Bensadoun H
    [Where do we stand with benign prostatic hyperplasia day-case surgery: A laser effect?]
    Prog Urol. 2018 Jun 12. pii: S1166-7087(18)30121.
    PubMed     Text format     Abstract available


  13. BRUREAU L, Emeville E, Multigner L, Blanchet P, et al
    Predictors of biochemical recurrence after radical prostatectomy in an Afro-Caribbean population in Guadeloupe (French West Indies).
    Prog Urol. 2018;28.
    PubMed     Text format     Abstract available


  14. ALBISINNI S, Grosman J, Aoun F, Quackels T, et al
    Exploring positive surgical margins after minimally invasive radical prostatectomy: Does body habitus really make a difference ?
    Prog Urol. 2018;28.
    PubMed     Text format     Abstract available


    May 2018
  15. RAICHI A, Marcq G, Fantoni JC, Puech P, et al
    [Active surveillance in prostate cancer: Assessment of MRI in the selection and follow-up of patients].
    Prog Urol. 2018 May 31. pii: S1166-7087(18)30085.
    PubMed     Text format     Abstract available


  16. HACHI K, Boualga K, Chettibi K, Harouni M, et al
    [Study of the beneficial effects of triptorelin on lower urinary tract symptoms in Algeria in patients with non-localized prostate cancer].
    Prog Urol. 2018 May 20. pii: S1166-7087(18)30094.
    PubMed     Text format     Abstract available


  17. MARTIN-MALBURET A, Marcq G, Leroy X, Guiffart P, et al
    [Pathology findings after radical prostatectomy for prostate cancer in patients eligible for active surveillance: Contribution of multiparametric MRI to treatment decision].
    Prog Urol. 2018 May 20. pii: S1166-7087(18)30092.
    PubMed     Text format     Abstract available


    April 2018
  18. ROZET F, Hennequin C, Mongiat-Artus P, Beuzeboc P, et al
    [French CCAFU guidelines on prostate cancer: hormono-naive metastatic prostate cancer - update 2017].
    Prog Urol. 2018 Apr 18. pii: S1166-7087(18)30080.
    PubMed     Text format    


    March 2018
  19. GEVORGYAN A, Hetet JF, Robert M, Duchattelle-Dussaule V, et al
    [Salvage cryotherapy of prostate cancer after failed external radiotherapy and brachytherapy: Morbidity and mid-term oncological results].
    Prog Urol. 2018 Mar 15. pii: S1166-7087(17)30543.
    PubMed     Text format     Abstract available


    February 2018
  20. SARRADIN M, Lepiney C, Celhay O, Delpech PO, et al
    [Estimating minimum period of time to perform prostate MRI after prostate biopsy: Clinical and histological bleeding risk factors; from a prospective study].
    Prog Urol. 2018;28:85-93.
    PubMed     Text format     Abstract available


    January 2018
  21. ALBISINNI S, Aoun F, Noel A, El Rassy E, et al
    Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?
    Prog Urol. 2018;28:18-24.
    PubMed     Text format     Abstract available


    December 2017
  22. DE LA TAILLE A, Mardoyan S, Lafaye A
    [Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy].
    Prog Urol. 2017 Dec 6. pii: S1166-7087(17)30625.
    PubMed     Text format     Abstract available


  23. DE VERGIE S, Gaschignard N, Baron M, Branchereau J, et al
    [Long-term outcomes of prostate cancer patients with lymph nodes metastasis after radical prostatectomy and pelvic lymph node dissection].
    Prog Urol. 2017 Dec 5. pii: S1166-7087(17)30624.
    PubMed     Text format     Abstract available


    November 2017
  24. DEFONTAINES J, Salomon L, Champy C, Cholley I, et al
    [Prostate cancer diagnostic by saturation randomized biopsy versus rigid targeted biopsy].
    Prog Urol. 2017 Nov 6. pii: S1166-7087(17)30536.
    PubMed     Text format     Abstract available


    September 2017
  25. RENARD-PENNA R, Sanchez-Salas R, Barret E, Cosset JM, et al
    [Evaluation and results of ablative therapies in prostate cancer].
    Prog Urol. 2017 Sep 19. pii: S1166-7087(17)30455.
    PubMed     Text format     Abstract available


  26. BARRET E, Sanchez-Salas R, Galiano M, Cathala N, et al
    [Management of ablative therapies in prostate cancer].
    Prog Urol. 2017 Sep 14. pii: S1166-7087(17)30411.
    PubMed     Text format     Abstract available


  27. SANCHEZ-SALAS R, Barret E, Renard-Penna R, Cosset JM, et al
    [Indications and limits of ablative therapies in prostate cancer].
    Prog Urol. 2017 Sep 14. pii: S1166-7087(17)30456.
    PubMed     Text format     Abstract available


    June 2017
  28. MARIEN A, De Castro Abreu A, Gill I, Villers A, et al
    [Interest using 3D ultrasound and MRI fusion biopsy for prostate cancer detection].
    Prog Urol. 2017 Jun 16. pii: S1166-7087(17)30130.
    PubMed     Text format     Abstract available


    May 2017
  29. VIDMAR R, Marcq G, Flamand V, Fantoni JC, et al
    [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
    Prog Urol. 2017 May 30. pii: S1166-7087(17)30108.
    PubMed     Text format     Abstract available


  30. GIRIER D, Chevrot A, Costa P, Thuret R, et al
    [Sexual consequences after treatment of prostate cancer: Inquiry among members of the Association Nationale des Malades du Cancer de la Prostate].
    Prog Urol. 2017 May 5. pii: S1166-7087(17)30075.
    PubMed     Text format     Abstract available


    April 2017
  31. MONDET F, Alimi JC, Boyer C
    [Cancer plans apply to surgical treatment of prostate cancer: A geographically isolated center balance].
    Prog Urol. 2017 Apr 6. pii: S1166-7087(17)30046.
    PubMed     Text format     Abstract available


  32. ROZET F, Roupret M, Hennequin C, Massard C, et al
    [Management of a progressing prostate cancer: results of a national study].
    Prog Urol. 2017 Apr 6. pii: S1166-7087(17)30022.
    PubMed     Text format     Abstract available


    March 2017
  33. LONG JA, Poinas G, Fiard G, Lepretre M, et al
    [Robot assisted radical prostatectomy: What are the evidences at the time of a specific funding?]
    Prog Urol. 2017;27:146-157.
    PubMed     Text format     Abstract available


  34. LIMANI K, Albisinni S, Aoun F, Le Dinh D, et al
    [Quality of life after robotic prostatectomy: Impact of BMI and age on urinary incontinence].
    Prog Urol. 2017;27:244-252.
    PubMed     Text format     Abstract available


    November 2016
  35. COHEN J, Andre C, Mozer P
    [Targeted MRI prostate biopsies].
    Prog Urol. 2016;26:854-859.
    PubMed     Text format     Abstract available


    July 2016
  36. RIOUX-LECLERCQ N, Comperat E, Kammerer-Jacquet SF, Camparo P, et al
    [Pathological advances in renal, prostatic, bladder and testis neoplasia].
    Prog Urol. 2016 Jul 26. pii: S1166-7087(16)30070.
    PubMed     Text format     Abstract available


    May 2016
  37. BARRE C, Nguyen JM
    [Addendum concerning: "A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre: Oncologic and functional outcomes" written by J.B. Beauval et al. [Prog. Urol. 25 (2015) 370-
    Prog Urol. 2016;26:383-4.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: